Stem Cell Pioneer Joins Forces with Stem Cell Fraudster
By Ahn Mi-Young and Dennis Normile,
Science Insider
| 02. 10. 2015
Untitled Document
The scientist who once fraudulently claimed to have created embryonic stem cells matched to human patients and the one who really did it plan to conduct joint research, a Korean newspaper reported this morning. A Chinese regenerative medicine company will provide financial support, according to the account.
The two scientists would seem an odd match. In 2006, Woo Suk Hwang had to retract two papers published in Science in which his team claimed it had used the technique employed in cloning Dolly the sheep to create human embryonic stem cells matched to specific people who had various diseases. After investigators determined all the claims were bogus, Hwang was fired from Seoul National University and later convicted of embezzling research funds and bioethics violations. He escaped jail time with a suspended sentence. Since his downfall, Hwang has quietly continued his cloning work on animals, particularly pet dogs, at Seoul-based Sooam Biotech Research Foundation, a private institute friends established specifically for him.
Despite his claims being deemed fraudulent by a Seoul National University panel, Hwang was awarded an...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...